Barrett J C
Cancer Res. 1987 May 1;47(9):2514-20.
A workshop organized by the Chemical Pathology Study Section was convened to discuss recent findings on the suppression and/or reversal of neoplastic transformation. The existence of specific genes involved in suppressing tumorigenicity has been clearly demonstrated by molecular and cytogenetic analyses of tumor and normal cells from individuals predisposed to develop specific malignancies and by studies of hybrids between normal and neoplastic cells. The malignancy of tumor cells can be suppressed in hybrids with normal cells despite the continued expression of activated oncogenes. Reversal of the malignant state can also be affected by placing tumor cells in certain embryonic environments, such as the mouse blastocyst, or in response to differentiation inducing factors. The numerous examples of suppression and reversal of malignancy indicate that this is an important area for future study which may lead to new methods to control cancer.
由临床化学研究组组织的一次研讨会召开,以讨论肿瘤转化抑制和/或逆转方面的最新发现。通过对易患特定恶性肿瘤个体的肿瘤细胞和正常细胞进行分子和细胞遗传学分析,以及对正常细胞与肿瘤细胞的杂交细胞进行研究,已清楚地证明了存在参与抑制致瘤性的特定基因。尽管激活的癌基因持续表达,但肿瘤细胞与正常细胞杂交后,其恶性程度可被抑制。将肿瘤细胞置于某些胚胎环境中,如小鼠囊胚,或在分化诱导因子的作用下,也可影响恶性状态的逆转。恶性肿瘤抑制和逆转的众多实例表明,这是一个未来研究的重要领域,可能会带来控制癌症的新方法。